These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23331500)

  • 1. Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease.
    Alexandre J; Saloux E; Dugué AE; Lebon A; Lemaitre A; Roule V; Labombarda F; Provost N; Gomes S; Scanu P; Milliez P
    J Cardiovasc Magn Reson; 2013 Jan; 15(1):12. PubMed ID: 23331500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular scar burden specifies the potential for ventricular arrhythmogenesis: an LGE-CMR study.
    Scott PA; Rosengarten JA; Murday DC; Peebles CR; Harden SP; Curzen NP; Morgan JM
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):430-6. PubMed ID: 23210601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can QRS scoring predict left ventricular scar and clinical outcomes?
    Rosengarten JA; Scott PA; Chiu OK; Shambrook JS; Curzen NP; Morgan JM
    Europace; 2013 Jul; 15(7):1034-41. PubMed ID: 23493411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of life-threatening arrhythmic events in patients with chronic myocardial infarction by contrast-enhanced CMR.
    Boyé P; Abdel-Aty H; Zacharzowsky U; Bohl S; Schwenke C; van der Geest RJ; Dietz R; Schirdewan A; Schulz-Menger J
    JACC Cardiovasc Imaging; 2011 Aug; 4(8):871-9. PubMed ID: 21835379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R; Chaudhry U; van der Pals J; Engblom H; Arheden H; Heiberg E; Wu KC; Borgquist R; Carlsson M
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28838961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scar extent as a predictive factor of ventricular tachycardia cycle length after myocardial infarction: implications for implantable cardioverter-defibrillator programming optimization.
    Alexandre J; Saloux E; Lebon A; Dugué AE; Lemaitre A; Roule V; Labombarda F; Champ-Rigot L; Gomes S; Pellissier A; Scanu P; Milliez P
    Europace; 2014 Feb; 16(2):220-6. PubMed ID: 24186956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy.
    Rayatzadeh H; Tan A; Chan RH; Patel SJ; Hauser TH; Ngo L; Shaw JL; Hong SN; Zimetbaum P; Buxton AE; Josephson ME; Manning WJ; Nezafat R
    J Cardiovasc Magn Reson; 2013 Apr; 15(1):31. PubMed ID: 23574733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complexity of scar and ventricular arrhythmias in dilated cardiomyopathy of any etiology: Long-term data from the SCARFEAR (Cardiovascular Magnetic Resonance Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy Delivery) Registry.
    Pedretti S; Vargiu S; Baroni M; Dellegrottaglie S; Lanzarin B; Roghi A; Milazzo A; Quattrocchi G; Lunati M; Pedrotti P
    Clin Cardiol; 2018 Apr; 41(4):494-501. PubMed ID: 29663442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators.
    Scott PA; Morgan JM; Carroll N; Murday DC; Roberts PR; Peebles CR; Harden SP; Curzen NP
    Circ Arrhythm Electrophysiol; 2011 Jun; 4(3):324-30. PubMed ID: 21493964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infarct tissue characterization in implantable cardioverter-defibrillator recipients for primary versus secondary prevention following myocardial infarction: a study with contrast-enhancement cardiovascular magnetic resonance imaging.
    Olimulder MA; Kraaier K; Galjee MA; Scholten MF; van Es J; Wagenaar LJ; van der Palen J; von Birgelen C
    Int J Cardiovasc Imaging; 2013 Jan; 29(1):169-76. PubMed ID: 22684301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of cardiovascular magnetic resonance-derived circumferential strain parameters with the risk of ventricular arrhythmia and all-cause mortality in patients with prior myocardial infarction and primary prevention implantable cardioverter defibrillator.
    Paiman EHM; Androulakis AFA; Shahzad R; Tao Q; Zeppenfeld K; Lamb HJ; van der Geest RJ
    J Cardiovasc Magn Reson; 2019 May; 21(1):28. PubMed ID: 31096987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible Cause of Cardiac Arrest and Secondary Prevention Implantable Cardioverter Defibrillators in Patients With Coronary Artery Disease: Value of Complete Revascularization and LGE-CMR.
    van der Lingen ACJ; Becker MAJ; Kemme MJB; Rijnierse MT; Spoormans EM; Timmer SAJ; van Rossum AC; van Halm VP; Germans T; Allaart CP
    J Am Heart Assoc; 2021 Apr; 10(8):e019101. PubMed ID: 33821672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress Perfusion CMR in Patients With Known and Suspected CAD: Prognostic Value and Optimal Ischemic Threshold for Revascularization.
    Vincenti G; Masci PG; Monney P; Rutz T; Hugelshofer S; Gaxherri M; Muller O; Iglesias JF; Eeckhout E; Lorenzoni V; Pellaton C; Sierro C; Schwitter J
    JACC Cardiovasc Imaging; 2017 May; 10(5):526-537. PubMed ID: 28412420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between left ventricular scar and ventricular repolarization in patients with coronary artery disease: insights from late gadolinium enhancement magnetic resonance imaging.
    Scott PA; Rosengarten JA; Shahed A; Yue AM; Murday DC; Roberts PR; Peebles CR; Harden SP; Curzen NP; Morgan JM
    Europace; 2013 Jun; 15(6):899-906. PubMed ID: 23143860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes after primary prevention defibrillator implantation are better predicted when the left ventricular ejection fraction is assessed by cardiovascular magnetic resonance.
    Champ-Rigot L; Gay P; Seita F; Benouda L; Morello R; Pellissier A; Alexandre J; Saloux E; Milliez P
    J Cardiovasc Magn Reson; 2020 Jun; 22(1):48. PubMed ID: 32580786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.
    Piers SR; Everaerts K; van der Geest RJ; Hazebroek MR; Siebelink HM; Pison LA; Schalij MJ; Bekkers SC; Heymans S; Zeppenfeld K
    Heart Rhythm; 2015 Oct; 12(10):2106-14. PubMed ID: 26004942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late gadolinium enhancement by cardiovascular magnetic resonance is complementary to left ventricle ejection fraction in predicting prognosis of patients with stable coronary artery disease.
    Catalano O; Moro G; Perotti M; Frascaroli M; Ceresa M; Antonaci S; Baiardi P; Napolitano C; Baldi M; Priori SG
    J Cardiovasc Magn Reson; 2012 May; 14(1):29. PubMed ID: 22607320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scar channels in cardiac magnetic resonance to predict appropriate therapies in primary prevention.
    Sánchez-Somonte P; Quinto L; Garre P; Zaraket F; Alarcón F; Borràs R; Caixal G; Vázquez S; Prat S; Ortiz-Perez JT; Perea RJ; Guasch E; Tolosana JM; Berruezo A; Arbelo E; Sitges M; Mont L; Roca-Luque I
    Heart Rhythm; 2021 Aug; 18(8):1336-1343. PubMed ID: 33892202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-contrast late enhancement CMR determined gray zone and papillary muscle involvement predict appropriate ICD therapy in patients with ischemic heart disease.
    Yang Y; Connelly KA; Zeidan-Shwiri T; Lu Y; Paul G; Roifman I; Zia MI; Graham JJ; Dick AJ; Crystal E; Wright GA
    J Cardiovasc Magn Reson; 2013 Jun; 15(1):57. PubMed ID: 23803259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.